| Active ingredients | Statut | Update | Specialty |
| methylprednisolone (sodium hydrogen succinate) | Supply tension | 29/08/2025 | Methylprednisolone Hikma 500 mg, powder for injectable solution |
| dipyridamole | Supply tension | 29/08/2025 | Persantine 10 mg/2 mL, solution injectable, ampoule |
| VaricellaZoster Virus (VZV) glycoprotein E antigen (recombinant, adjuvanted) (mammalian/hamster/CHO cells) | Supply tension | 29/08/2025 | Shingrix, powder and suspension for injectable suspension. Varicella zoster vaccine (recombinant, adjuvanted) |
| fludarabine (phosphate) | Return to availability | 28/08/2025 | Fludarabine Teva 25 mg/mL, diluent solution for injection/infusion |
| atropine (sulfate) | Supply tension | 27/08/2025 | Atropine 0.3%, eye drops |
| methylphenidate hydrochloride | Supply tension | 27/08/2025 | Concerta LP, extendedrelease tablet |
| linezolid | Return to availability | 27/08/2025 | Linezolid 2 mg/mL, solution for infusion |
| venlafaxine | Supply tension | 27/08/2025 | Specialties based on Venlafaxine LP 37.5 mg and LP 75 mg sustainedrelease capsules |
| clomipramine (hydrochloride) | Stock shortage | 27/08/2025 | Anafranil 25 mg, coated tablet |
| cytarabine | Supply tension | 26/08/2025 | Cytarabine Sandoz 100 mg/ml, solution for injection 1 glass bottle(s) of 50 ml |
| glucagon (hydrochloride) | Return to availability | 26/08/2025 | GlucaGen Kit 1 mg/ml, powder and solvent for solution for injection |
| acetylcholine chloride | Supply tension | 26/08/2025 | Miochole 20 mg, powder and solvent for intraocular solution |
| sitagliptin | Supply tension | 26/08/2025 | Specialties based on Sitagliptin 50 mg |
| tobramycin | Stock shortage | 26/08/2025 | Tobi Podhaler 28 mg, powder for inhalation capsule |
| linezolid | Return to availability | 25/08/2025 | Linezolid 600 mg, filmcoated tablet |
| methylprednisolone (sodium hydrogen succinate) | Supply tension | 25/08/2025 | Methylprednisolone Hikma 40 mg, powder for injectable solution |
| Active ingredients | AM designation | Message type | Date of last message | Type of reason |
| Epinephrine hydrochloride | Suprarenin ampoules | Change notification | 29.08.2025 | Production problem |
| Norepinephrine hydrochloride/noradrenaline hydrochloride | Arterenol 1 ml | Change notification | 29.08.2025 | Production problem |
| Isophane insulin suspension for injection (Ph.Eur.) | Protaphane FlexPen 100 IU/ml injection suspension in injector – OP (10x3ml) | Initial report | 29.08.2025 | Other |
| Sodium (methylprednisolone-21-succinate) | Urbason solubile forte 1000 mg | Change notification | 29.08.2025 | Other |
| Doxepin hydrochloride (Ph.Eur.) | Doxepin 25 Holsten | Change notification | 29.08.2025 | Production problem |
| Olanzapine embonate monohydrate | ZYPADHERA 405 mg powder and solvent for the preparation of a depot injection suspension – OP(931mg+3ml) | Change notification | 29.08.2025 | Production problem |
| Olanzapine embonate monohydrate | ZYPADHERA 300 mg powder and solvent for the preparation of a prolonged-release injection suspension – OP(690mg+3ml) | Change notification | 29.08.2025 | Production problem |
| Terazosin hydrochloride dihydrate | Tera TAD 2mg | Change notification | 28.08.2025 | Other |
| Terazosin hydrochloride dihydrate | Tera TAD 5mg | Change notification | 28.08.2025 | Other |
| Terazosin hydrochloride dihydrate | Tera TAD 10mg | Change notification | 28.08.2025 | Other |
| Oxcarbazepine | Oxcarbazepine – 1 A Pharma 60 mg/ml oral suspension | Initial report | 28.08.2025 | Other |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine-Hormosan 200 mg prolonged-release tablets | Change notification | 28.08.2025 | Other |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine Hormosan 300 mg prolonged-release tablets | Change notification | 28.08.2025 | Other |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine-Hormosan 400 mg prolonged-release tablets | Change notification | 28.08.2025 | Other |
| Medium-chain triglycerides; omega-3 acid triglycerides (with information on origin and/or composition); refined soybean oil (Ph.Eur.) | Lipidem Emulsion for infusion | Initial report | 28.08.2025 | Production problem |
| Quetiapine fumarate (Ph.Eur.) | Seroquel Prolong 150 mg prolonged-release tablets | Initial report | 28.08.2025 | Other |
| Calcitriol | Calcitriol KyraMed 0.25 micrograms | Initial report | 28.08.2025 | Other |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine – 1 A Pharma 600 mg prolonged-release tablets | Change notification | 28.08.2025 | Production problem |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine – 1 A Pharma 50 mg prolonged-release tablets | Change notification | 28.08.2025 | Production problem |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine – 1 A Pharma 400 mg prolonged-release tablets | Change notification | 28.08.2025 | Production problem |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine – 1 A Pharma 300 mg prolonged-release tablets | Change notification | 28.08.2025 | Production problem |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine – 1 A Pharma 200 mg prolonged-release tablets | Change notification | 28.08.2025 | Production problem |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine – 1 A Pharma 150 mg prolonged-release tablets | Change notification | 28.08.2025 | Production problem |
| Sevelamer | Renagel 800 mg film-coated tablets – OP(1×180) | Initial report | 28.08.2025 | Other |
| Paliperidone palmitate | Paliperidone AL 25 mg Depot injection suspension in a pre-filled syringe | Change notification | 28.08.2025 | Other |
| Paliperidone palmitate | Paliperidone AL 150 mg depot injection suspension in a pre-filled syringe | Change notification | 28.08.2025 | Other |
| Duloxetine hydrochloride | Duloxetine AL 120 mg gastro-resistant hard capsules | Change notification | 28.08.2025 | Other |
| Aprepitant | Aprepitant STADA 80 mg hard capsules | Change notification | 28.08.2025 | Production problem |
| Methylphenidate hydrochloride | Methylphenidate AL 18 mg prolonged-release tablets | Change notification | 28.08.2025 | Other |
| Ipratropium bromide (Ph.Eur.) | Ipratropium Teva 250 micrograms/1 ml solution for nebulizer | Change notification | 28.08.2025 | Production problem |
| Oxazepam | Oxa-CT 10 mg tablets | Change notification | 28.08.2025 | Other |
| Ribavirin | Ribavirin-ratiopharm 200 mg film-coated tablets | Change notification | 28.08.2025 | Other |
| Ribavirin | Ribavirin-ratiopharm 400 mg film-coated tablets | Change notification | 28.08.2025 | Other |
| Carbamazepine | Carbamazepine-ratiopharm 200 mg prolonged-release tablets | Change notification | 28.08.2025 | Other |
| Oxazepam | Oxazepam-ratiopharm 10 mg tablets | Change notification | 28.08.2025 | Other |
| Pramipexole dihydrochloride monohydrate | Pramipexole-ratiopharm 0.52 mg prolonged-release tablets | Change notification | 28.08.2025 | Other |
| Rosuvastatin Hemicalcium | Rosuvastatin Aristo 5 mg film-coated tablets | Change notification | 27.08.2025 | Production problem |
| Rosuvastatin Hemicalcium | Rosuvastatin Aristo 20 mg film-coated tablets | Change notification | 27.08.2025 | Other |
| Rosuvastatin Hemicalcium | Rosuvastatin Aristo 10 mg film-coated tablets | Change notification | 27.08.2025 | Other |
| Melperone hydrochloride | Melperone Aristo 50 mg film-coated tablets | Change notification | 27.08.2025 | Other |
| Melperone hydrochloride | Melperon Aristo 100 mg film-coated tablets | Change notification | 27.08.2025 | Production problem |
| Oxazepam | Oxazepam AL 10 | Change notification | 27.08.2025 | Other |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Atorvastatin Aristo 60 mg film-coated tablets | Change notification | 27.08.2025 | Other |
| Codeine phosphate hemihydrate; caffeine; paracetamol | Azur compositum | Change notification | 27.08.2025 | Other |
| Esomeprazole hemimagnesium | ESOMEPRAZOLE BASICS 40 mg gastro-resistant hard capsules | Change notification | 27.08.2025 | Production problem |
| Esomeprazole hemimagnesium | ESOMEPRAZOLE BASICS 20 mg gastro-resistant hard capsules | Change notification | 27.08.2025 | Production problem |
| Clarithromycin | CLARITHROMYCIN BASICS 250 mg/5 ml granules for oral suspension | Change notification | 27.08.2025 | Production problem |
| Chlortalidone | Chlortalidone HEXAL 50 mg tablets | Change notification | 27.08.2025 | Other |
| Chlortalidone | Chlortalidone HEXAL 25 mg tablets | Change notification | 27.08.2025 | Other |
| Pramipexole dihydrochloride monohydrate | Pramipexole Mylan 3.15 mg prolonged-release tablets | Initial report | 27.08.2025 | Other |
| Amikacin sulfate | Amikacin B. Braun 5 mg/ml solution for infusion | Initial report | 27.08.2025 | Production problem |
| Amikacin sulfate | Amikacin B. Braun 2.5 mg/ml solution for infusion | Initial report | 27.08.2025 | Production problem |
| Calcitriol | Renatriol 0.25 µg | Initial report | 26.08.2025 | Other |
| Anastrozole | Anastrozole Denk 1 mg film-coated tablets | Initial report | 26.08.2025 | Other |
| Clopidogrel besylate | Clopidogrel Denk 75 mg film-coated tablets | Change notification | 26.08.2025 | Other |
| Ketotifen fumarate | Ketotifen STADA 1 mg hard capsules | Change notification | 26.08.2025 | Production problem |
| Midodrine hydrochloride | Gutron tablets | Change notification | 26.08.2025 | Other |
| Clomethiazole hemidisilate | Distraneurin mixture | Initial report | 25.08.2025 | Other |
| Pramipexole dihydrochloride monohydrate | Pramipexole – 1 A Pharma 0.26 mg prolonged-release tablets | Change notification | 25.08.2025 | Other |
| Sodium mycophenolate | Mycophenolic acid HEXAL 360 mg gastro-resistant tablets | Change notification | 25.08.2025 | Other |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine HEXAL 50 mg prolonged-release tablets | Change notification | 25.08.2025 | Production problem |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine HEXAL 400 mg prolonged-release tablets | Change notification | 25.08.2025 | Production problem |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine HEXAL 300 mg prolonged-release tablets | Change notification | 25.08.2025 | Production problem |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine HEXAL 200 mg prolonged-release tablets | Change notification | 25.08.2025 | Production problem |
| Quetiapine fumarate (Ph.Eur.) | Quetiapine HEXAL 150 mg prolonged-release tablets | Change notification | 25.08.2025 | Production problem |
| Methylphenidate hydrochloride | Methylphenidate hydrochloride – 1 A Pharma 36 mg prolonged-release tablets | Change notification | 25.08.2025 | Other |
| Methylphenidate hydrochloride | Methylphenidate hydrochloride HEXAL 36 mg prolonged-release tablets | Change notification | 25.08.2025 | Other |
| Insulin glargine | Semglee 100 units/ml solution for injection in pre-filled pen – OP(5x3ml) | Change notification | 25.08.2025 | Other |
| Levetiracetam | Levetiracetam – 1 A Pharma 1500 mg film-coated tablets | Change notification | 25.08.2025 | Other |
| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| methylphenidate hydrochloride | Tablet, uncoated | 10 mg | Resolved | Available | Manufacturing | 29/08/2025 |
| lincomycin hydrochloride monohydrate | Injection, solution | 340.26 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 29/08/2025 |
| risperidone | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 29/08/2025 |
| midazolam | Injection, solution | 5 mg/mL | Current | Limited Availability | Manufacturing | 29/08/2025 |
| olanzapine pamoate monohydrate | Injection, powder for | 483 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 29/08/2025 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Current | Limited Availability | Manufacturing | 29/08/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.512 mg | Current | Unavailable | Manufacturing | 29/08/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.768 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 29/08/2025 |
| midazolam | Injection, solution | 50 mg | Current | Limited Availability | Manufacturing | 29/08/2025 |
| vecuronium bromide | Injection, powder for | 10 mg | Anticipated | Available | Manufacturing | 29/08/2025 |
| Somatropin | Injection, powder for | 12 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 29/08/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Unavailable | Unexpected increase in consumer demand | 29/08/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 29/08/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 29/08/2025 |
| ketorolac trometamol | Injection, solution | 30 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 29/08/2025 |
| cisatracurium besilate | Injection, solution | 7.04 mg | Anticipated | Available | Manufacturing | 29/08/2025 |
| lamotrigine | Tablet, uncoated | 200 mg | Current | Limited Availability | Manufacturing | 29/08/2025 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Current | Limited Availability | Manufacturing | 29/08/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 10.845 mg | Resolved | Available | Manufacturing | 29/08/2025 |
| moxonidine | Tablet, film coated | 400 microgram | Anticipated | Available | Commercial Changes / Commercial viability | 29/08/2025 |
| moxonidine | Tablet, film coated | 200 microgram | Anticipated | Available | Commercial Changes / Commercial viability | 29/08/2025 |
| posaconazole | Tablet, modified release | 100 mg | Current | Unavailable | Manufacturing | 29/08/2025 |
| mesalazine | Tablet, enteric coated | 1.6 g | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 29/08/2025 |
| midazolam maleate | Solution | 10.2 mg | Current | Limited Availability | Manufacturing | 29/08/2025 |
| lorazepam | Tablet | 1 mg | Current | Limited Availability | Manufacturing | 29/08/2025 |
| tamoxifen citrate | Tablet, uncoated | 15.2 mg | Current | Unavailable | Manufacturing | 29/08/2025 |
| tamoxifen citrate | Tablet, uncoated | 30.4 mg | Current | Unavailable | Manufacturing | 29/08/2025 |
| trandolapril | Capsule, hard | 2 mg | Current | Unavailable | Manufacturing | 29/08/2025 |
| lidocaine hydrochloride monohydrate | Injection, solution | 10 mg/mL | Current | Limited Availability | Manufacturing | 29/08/2025 |
| terbinafine hydrochloride | Tablet, uncoated | 281.25 mg | Current | Limited Availability | Manufacturing | 28/08/2025 |
| live varicella vaccine | Injection, powder for | 2700 PFU/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 28/08/2025 |
| glimepiride | Tablet, uncoated | 1 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| risperidone | Tablet, film coated | 2 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| risperidone | Tablet, film coated | 3 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| topiramate | Tablet, film coated | 25 mg | Current | Limited Availability | Manufacturing | 28/08/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| lamotrigine | Tablet, chewable | 200 mg | Current | Limited Availability | Manufacturing | 28/08/2025 |
| fentanyl | Drug delivery system, transdermal | 16.8 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 28/08/2025 |
| risperidone | Tablet, film coated | 2 mg | Anticipated | Available | Manufacturing | 28/08/2025 |
| bisoprolol fumarate | Tablet | 2.5 mg | Anticipated | Available | Manufacturing | 28/08/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 49.59 mg | Resolved | Available | Manufacturing | 28/08/2025 |
| mycophenolate mofetil | Capsule | 250 mg | Resolved | Available | Manufacturing | 28/08/2025 |
| levetiracetam | Tablet, film coated | 500 mg | Anticipated | Available | Manufacturing | 28/08/2025 |
| ondansetron hydrochloride dihydrate | Tablet, film coated | 9.972 mg | Current | Limited Availability | Manufacturing | 28/08/2025 |
| metronidazole | Tablet, uncoated | 400 mg | Current | Limited Availability | Manufacturing | 28/08/2025 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Unexpected increase in consumer demand | 28/08/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| sumatriptan succinate | Tablet, film coated | 69.99 mg | Anticipated | Available | Manufacturing | 28/08/2025 |
| finasteride | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 555 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| trandolapril | Capsule, hard | 1 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| trandolapril | Capsule, hard | 2 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| trandolapril | Capsule, hard | 4 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Anticipated | Available | Manufacturing | 28/08/2025 |
| lansoprazole | Tablet, orally disintegrating | 30 mg | Current | Limited Availability | Manufacturing | 28/08/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.98 mg | Current | Limited Availability | Manufacturing | 28/08/2025 |
| linezolid | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| anastrozole | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| solifenacin succinate | Tablet | 10 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| irbesartan | Tablet, film coated | 300 mg | Resolved | Available | Manufacturing | 28/08/2025 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 12.5 mg~300 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| tadalafil | Tablet, film coated | 20 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 28/08/2025 |
| nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Current | Unavailable | Manufacturing | 28/08/2025 |
| bimatoprost | Eye Drops | .3 mg/mL | Anticipated | Available | Manufacturing | 28/08/2025 |
| phenytoin sodium | Capsule, hard | 30 mg | Current | Limited Availability | Manufacturing | 28/08/2025 |
| ropinirole hydrochloride | Tablet, film coated | .285 mg | Anticipated | Available | Manufacturing | 28/08/2025 |
| metaraminol tartrate | Injection, solution | 19 mg | Current | Limited Availability | Manufacturing | 28/08/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.376 mg | Resolved | Available | Manufacturing | 28/08/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.376 mg | Resolved | Available | Manufacturing | 28/08/2025 |
| flucloxacillin sodium monohydrate | Injection, powder for | 544.1 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 28/08/2025 |
| lamotrigine | Tablet, chewable | 100 mg | Anticipated | Available | Manufacturing | 28/08/2025 |
| buprenorphine hydrochloride | Tablet, uncoated | .216 mg | Resolved | Available | Manufacturing | 28/08/2025 |
| hyoscine butylbromide | Injection, solution | 20 mg | Current | Limited Availability | Manufacturing | 28/08/2025 |
| sugammadex sodium | Injection, solution | 217.6 mg | Current | Limited Availability | Manufacturing | 28/08/2025 |
| naltrexone hydrochloride | Tablet, film coated | 50 mg | Anticipated | Available | Manufacturing | 28/08/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 28/08/2025 |
| metformin hydrochloride~sitagliptin hydrochloride monohydrate | Tablet, film coated | 500 mg~56.69 mg | Resolved | Available | Manufacturing | 28/08/2025 |
| metformin hydrochloride~sitagliptin hydrochloride monohydrate | Tablet, film coated | 850 mg~56.69 mg | Resolved | Available | Manufacturing | 28/08/2025 |
| carboplatin | Injection, solution | 10 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 28/08/2025 |
| phenytoin sodium | Injection, solution | 250 mg | Anticipated | Available | Manufacturing | 28/08/2025 |
| silver sulfadiazine | Cream | 10 mg/g | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 27/08/2025 |
| silver sulfadiazine | Cream | 10 mg/g | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 27/08/2025 |
| doxylamine succinate | Tablet, uncoated | 25 mg | Current | Limited Availability | Unexpected increase in consumer demand | 27/08/2025 |
| docetaxel | Injection, concentrated | 80 mg | Anticipated | Available | Manufacturing | 27/08/2025 |
| azacitidine | Injection, powder for | 100 mg | Current | Limited Availability | Manufacturing | 27/08/2025 |
| metronidazole | Injection, solution | 500 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 27/08/2025 |
| sertraline hydrochloride | Tablet, film coated | 112 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 26/08/2025 |
| sodium pyrophosphate | Injection, powder for | 30 mg | Current | Unavailable | Manufacturing | 26/08/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Emergency Supply Only | Unexpected increase in demand due to other sponsors unable to supply | 26/08/2025 |
| pantoprazole sodium sesquihydrate | Tablet, enteric coated | 45.4 mg | Current | Limited Availability | Unexpected increase in consumer demand | 26/08/2025 |
| sulfamethoxazole~trimethoprim | Injection, concentrated | 80 mg/mL~16 mg/mL | Current | Limited Availability | Manufacturing | 26/08/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Limited Availability | Unexpected increase in consumer demand | 26/08/2025 |
| sulfamethoxazole~trimethoprim | Tablet, uncoated | 800 mg~160 mg | Current | Limited Availability | Manufacturing | 26/08/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 26/08/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in consumer demand | 26/08/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 26/08/2025 |
| clopidogrel besilate | Tablet, film coated | 112.1 mg | Current | Unavailable | Manufacturing | 26/08/2025 |
| midazolam hydrochloride | Injection, solution | 5.56 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 26/08/2025 |
| rosuvastatin calcium | Tablet, film coated | 10.42 mg | Current | Unavailable | Manufacturing | 26/08/2025 |
| pregabalin | Capsule, hard | 150 mg | Current | Limited Availability | Manufacturing | 26/08/2025 |
| pregabalin | Capsule, hard | 75 mg | Current | Unavailable | Manufacturing | 26/08/2025 |
| daptomycin | Injection, powder for | 350 mg | Resolved | Available | Manufacturing | 26/08/2025 |
| topotecan hydrochloride | Injection, concentrated | 4.346 mg | Current | Limited Availability | Unexpected increase in consumer demand | 26/08/2025 |
| paclitaxel | Injection, powder for | 100 mg | Current | Unavailable | Manufacturing | 26/08/2025 |
| metoprolol succinate | Tablet, modified release | 47.5 mg | Current | Unavailable | Manufacturing | 26/08/2025 |
| daptomycin | Injection, powder for | 500 mg | Current | Unavailable | Manufacturing | 26/08/2025 |
| daptomycin | Inhalation, powder for | 350 mg | Current | Unavailable | Manufacturing | 26/08/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 26/08/2025 |
| indocyanine green | Injection, powder for | 25 mg | Current | Unavailable | Manufacturing | 26/08/2025 |
| labetalol hydrochloride | Tablet, film coated | 100 mg | Current | Limited Availability | Manufacturing | 26/08/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 26/08/2025 |
| betiatide | Injection, powder for | 1 mg | Resolved | Available | Manufacturing | 25/08/2025 |
| irinotecan hydrochloride trihydrate | Injection, concentrated | 100 mg | Resolved | Available | Manufacturing | 25/08/2025 |
| carboplatin | Injection, solution | 450 mg | Current | Limited Availability | Manufacturing | 25/08/2025 |
| articaine hydrochloride~adrenaline (epinephrine) acid tartrate | Injection, solution | 40 mg/mL~18.2 microgram/mL | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 25/08/2025 |
| escitalopram oxalate | Tablet, film coated | 12.74 mg | Current | Unavailable | Commercial Changes / Commercial viability | 25/08/2025 |
| methylphenidate hydrochloride | Capsule, hard | 20 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 25/08/2025 |
| carboplatin | Injection, solution | 450 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 25/08/2025 |
